• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Terce Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3500.0
  • ISIN : INE499G01013
53.81 6 (11.45%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    48.00

  • Today’s High

    54.74

  • Open

    48.75

  • Perv Close

    48.28

  • 52W Low

    44.52

  • 52W High

    94.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    39.93

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.73

  • Debt-Equity Ratio

    11.45

  • AGM Date

    30-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    39.93

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.42

  • BV (₹)

    8.70

  • Sales( ₹ in Cr.)

    50.20

  • NP (in Cr.)

    -0.98

  • NP Var(%)

    -502.0

  • Div%

    0.0

  • CPS (₹)

    -0.80

  • EPS (₹)

    -1.30

  • Traded Value (₹ in Lakhs)

    39.93

  • 52 Week High

    94.90

  • 52 Week Low

    44.52

  • Price BSE

    54.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    39.93

  • P/C Ratio

    -67.40

  • P/E Ratio

    -40.90

  • Price Vs.BV

    -1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 47.97 46.78 40.13 25.18 37.54 31.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 47.97 46.78 40.13 25.18 37.54 31.03
Other Income 0.32 0.35 0.31 0.80 0.29 0.32
Stock Adjustments -1.04 -1.65 2.63 0.26 0.37 -0.19
Total Income 47.25 45.48 43.07 26.24 38.20 31.16
EXPENDITURE :            
Raw Materials 16.65 17.70 17.88 10.25 14.28 11.84
Power and Fuel Cost 0.17 0.11 0.16 0.10 0.10 0.08
Employee Cost 15.11 14.38 15.49 12.63 14.81 12.82
Other Manufacturing Expenses 0.22 0.44 1.58 0.93 1.07 0.89
Selling and Administration Expenses 13.44 14.57 5.97 3.93 6.02 3.85
Miscellaneous Expenses 0.07 0.10 0.56 0.37 0.95 0.89
Employee Benefit Expenses 15.11 14.38 15.49 12.63 14.81 12.82
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 45.67 47.29 41.65 28.20 37.24 30.36
Operating Profit 1.59 -1.81 1.42 -1.97 0.97 0.81
Interest 0.68 0.72 0.40 0.39 0.29 0.25
Gross Profit 0.91 -2.53 1.02 -2.36 0.68 0.56
Depreciation 0.37 0.36 0.28 0.18 0.24 0.21
Profit Before Tax 0.54 -2.89 0.74 -2.54 0.44 0.35
Current Tax 0.00 0.00 0.00 0.00 0.21 0.13
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.30 -1.22 -0.13 -0.01 -0.05 -0.22
Reported Net Profit 0.24 -1.67 0.87 -2.52 0.28 0.43
Extraordinary Items 0.00 0.00 0.00 -0.18 0.00 0.00
Adjusted Net Profit 0.24 -1.67 0.87 -2.34 0.28 0.43
Adjustment below Net Profit 0.00 0.00 0.00 -0.93 0.00 0.00
P & L Balance brought forward -2.48 -0.80 -1.68 1.77 1.50 1.06
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -2.23 -2.48 -0.80 -1.68 1.77 1.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.33 -2.25 1.18 -3.40 0.37 0.58
Earnings Per Share(Adj)-Unit Curr 0.33 -2.25 1.18 -3.40 0.37 0.58
Book Value 9.58 9.25 11.50 10.33 14.97 14.60
Book Value(Adj)-Unit Curr 9.58 9.25 11.50 10.33 14.97 14.60

Shareholding Pattern

  • Promoter Group

    37.03%

  • Public Share Holding

    62.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,083,400 14.60 1,083,400 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,664,327 22.43 1,664,327 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,747,727 37.03 2,747,727 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 106,560 1.44 104,960 23
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 58,264 0.79 58,264 28
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,380,553 18.61 1,380,253 34
Individuals holding nominal share capital up to Rs. 1 lakh 3,022,770 40.74 1,851,070 13,585
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 104,426 1.41 104,426 88
Sub Total 4,672,573 62.97 3,498,973 13,758
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,420,300 100.00 6,246,700 13,764

Company Background

Gujarat Terce Laboratories LtdPharmaceuticals - Indian - Formulations

  • Gujarat Terce Laboratories Ltd
  • BSE Code : 3500.0
  • ISIN : INE499G01013

  • Incorporation Year

    1985

  • Registered Office

    122/2 Ravi Estate
    Bileshwarpura Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-079-6663 3706

  • FAX

  • Chairman

    Natwarbhai P Prajapati

  • Managing Director

    Aalap Prajapati

  • Company Secretary

  • Auditor

    M A Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Gujarat Terce Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Terce Labs. 53.81 48.30 47.97 -40.77 7.17
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92